García-Serrano Cristina, Artigues-Barberà Eva, Mirada Gloria, Estany Pepi, Sol Joaquim, Ortega Bravo Marta
Atenció Primària Institut Català de la Salut, Atenció Primària, 25007 Lleida, Spain.
Multidisciplinary Research Group on Therapeutics and Interventions in Primary Care (RETICAP Group), Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via de les Corts Catalanes, 587, 08007 Barcelona, Spain.
Vaccines (Basel). 2023 Oct 27;11(11):1649. doi: 10.3390/vaccines11111649.
Patients with inflammatory bowel disease (IBD) have a dysregulated immune system, being at high risk of opportunistic infections. Low vaccination rates hinder the prevention of such diseases. Therefore, we implemented an intervention to increase vaccination rates, and we aimed to evaluate the effect. We determined the change in professionals and the change in the vaccination rates after the intervention. A quasi-experimental study was carried out using data from 31 December 2016 to 31 December 2021. First, healthcare professionals specializing in IBD agreed on a vaccination protocol; then, this protocol was passed on to the professionals involved in vaccination. We evaluated the perception of knowledge, capacity, and intention to vaccinate patients with IBD among the professionals before and after the intervention with a survey. We also described the effectiveness of the intervention for already diagnosed patients and compared the vaccination rates between patients diagnosed prior to the intervention and newly diagnosed patients. The intervention resulted in an improved perception of knowledge, capacity, and intention to vaccinate patients with IBD among the professionals ( < 0.05). Moreover, during the post-intervention period, in the 315 patients, the vaccination rate increased for all immune-preventable diseases ( < 0.05). The professionals positively valued the intervention, and compliance with the recommended vaccination protocol in patients with IBD improved significantly.
炎症性肠病(IBD)患者的免疫系统失调,面临机会性感染的高风险。疫苗接种率低阻碍了此类疾病的预防。因此,我们实施了一项提高疫苗接种率的干预措施,并旨在评估其效果。我们确定了干预后专业人员的变化以及疫苗接种率的变化。利用2016年12月31日至2021年12月31日的数据进行了一项准实验研究。首先,IBD专科医疗专业人员商定了一项疫苗接种方案;然后,该方案传达给了参与疫苗接种的专业人员。我们通过一项调查评估了干预前后专业人员对IBD患者进行疫苗接种的知识、能力和意愿的认知。我们还描述了该干预措施对已确诊患者的有效性,并比较了干预前确诊患者和新确诊患者的疫苗接种率。干预使专业人员对IBD患者进行疫苗接种的知识、能力和意愿的认知得到改善(<0.05)。此外,在干预后期间,在315名患者中,所有可通过免疫预防的疾病的疫苗接种率均有所提高(<0.05)。专业人员对该干预措施给予了积极评价,IBD患者对推荐疫苗接种方案的依从性显著提高。